The amyloid cascade hypothesis of AD implies that reaching the threshold for parenchymal amyloid positivity at an earlier age should drive secondary effector tau pathology, with an earlier age-at-onset of AD [81]. The gene discussed is MAPT; the disease is Alzheimer disease.